Event Cycle Run Swim Trek
Your local area

The Unifying Challenge

Create your team or sign up as individual, and complete your own unique 100 mile challenge to highlight and support further research into potentially life changing treatments for Parkinson’s. Between 1 – 14 September 2021, join 41 other individuals or teams and aim to cover...


CP news

Joyce Cook walks over 300,000 steps for Cure Parkinson’s

On Monday 10 May, 86 year old Joyce Cook from Chorleywood crossed the finish line of her incredible 300,000 step challenge. To mark Parkinson’s Awareness Month, Joyce walked more than 10,000 steps each day for 30 days, beginning on 11 April (World Parkinson’s Day), to…


Something ‘LRRK -ing’ in the data

Over recent years, researchers have been identifying genetic variations associated with an increased risk of developing Parkinson’s. A recent study has thrown further light on the connection between certain genetic risk factors and Parkinson’s progression.


Further support for diabetes treatments for Parkinson’s

A research group in South Korea has published results of their trial which provide further evidence that diabetes treatments can slow down the development of Parkinson’s in people with diabetes.


Important phase 1 trial results for LRRK2 inhibitor drug

This week the biotech company Denali Therapeutics announced the results of a phase 1 clinical trial of their LRRK2 inhibitor drug called ‘DNL151’. Their findings have interesting implications for the Parkinson’s community.